CLDI Other: a negative outcome, -5.8%

On September 25, 2026, Calidi Biotherapeutics, Inc. reached its Other. The result was a negative outcome, and the stock moved -5.8% in the window around the event. It had already run -17.8% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.